text.skipToContent text.skipToNavigation
Pharma & Biotech

Liver-Derived Endothelial Cells, human, passage 2

Catalog #: HLECP2
Human Liver-Derived Endothelial Cells
Compare
AMP

Product Overview

Endothelial cells are the primary barrier cells that line blood vessels and sinusoids of the liver. Human Liver-derived Endothelial Cells (HLECs) are isolated and enriched from liver tissue, then cryopreserved for use in a wide range of research models.

HLECs are characterized for markers of endothelial cells, including CD31, CD32b, vWF, and LYVE-1 as shown by flow cytometry and maintain appropriate endothelial morphology over limited serial passaging.  Human liver-derived endothelial cells are derived from whole livers leading to a mixed population of vasular endothelial cells and sinusoidal endothelial cells.  

The recommended medium for HLECs is EGMTM 2 which is optimized for endothelial cell health and growth.

Benefits

Low passage

Applications

  • ADMETox
  • Liver Disease
  • NASH

Content & Storage

Content

Cryo Vial >800,000 cells

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok